The functional enrichments suggested potential interactions with five pathways mediated by AKT signaling such as PI3K/AKT signaling in cancer, PIP3 activates AKT signaling, AKT phosphorylates targets in the nucleus and PI5P PPA and IER3 regulate PI3K/AKT signaling (Figure 4B). Here, IER3 is linked to cancer.